XML 83 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:      
Net income including non-controlling interests $ 1,023,779 $ 1,858,470 $ 355,298
Adjustments to reconcile net income including non-controlling interests to net cash provided by operating activities:      
Depreciation, depletion and amortization 598,562 369,659 158,304
(Gain) loss on sale of assets 2,764 (523,767) (222,806)
Impairment 28,963 (344) 5
Deferred income taxes 295,548 28,341 (977)
Net gain from investment in unconsolidated affiliate (21,330) (34,366) 0
Net (gain) loss on derivative instruments (63,182) 208,128 589,641
Equity-based compensation expenses 46,108 61,269 15,476
Deferred financing costs amortization and other 505 3,194 12,992
Working capital and other changes:      
Change in accounts receivable, net (147,870) 84,041 (184,605)
Change in inventory (12,659) 8,756 2,168
Change in prepaid expenses (1,199) 3,423 5,605
Change in accounts payable, interest payable and accrued liabilities 78,267 (131,687) 184,517
Change in other assets and liabilities, net (8,405) (11,091) (1,482)
Net cash provided by operating activities 1,819,851 1,924,026 914,136
Cash flows from investing activities:      
Capital expenditures (905,673) (531,327) (212,820)
Acquisitions, net of cash acquired (361,609) (148,144) (590,097)
Proceeds from divestitures, net of cash divested 54,445 169,198 376,081
Costs related to divestitures 0 (11,368) (2,926)
Derivative settlements (268,887) (633,025) (270,118)
Derivative modifications 0 0 (220,889)
Proceeds from sale of investment in unconsolidated affiliate 40,612 428,231 0
Distributions from investment in unconsolidated affiliate 10,806 43,873 0
Net cash used in investing activities (1,430,306) (682,562) (920,769)
Cash flows from financing activities:      
Proceeds from revolving credit facilities 260,000 1,035,000 399,500
Principal payments on revolving credit facilities (260,000) (1,020,000) (906,500)
Proceeds from issuance of senior unsecured notes 0 0 850,000
Cash paid to settle Whiting debt 0 (2,154) 0
Deferred financing costs 0 (5,997) (22,251)
Proceeds from issuance of OMP common units, net of offering costs 0 0 86,467
Common control transaction costs 0 0 (5,675)
Purchases of treasury stock (239,339) (151,950) (100,000)
Tax withholding on vesting of equity-based awards (14,604) (41,752) 0
Dividends paid (500,304) (654,728) (111,905)
Distributions to non-controlling interests 0 0 (28,720)
Payments on finance lease liabilities (1,702) (1,299) (1,161)
Proceeds from warrants exercised 91,251 19,784 1,435
Net cash provided by (used in) financing activities (664,698) (823,096) 161,190
Increase (decrease) in cash, cash equivalents and restricted cash (275,153) 418,368 154,557
Cash, cash equivalents and restricted cash:      
Beginning of period 593,151 174,783 20,226
End of period 317,998 593,151 174,783
Supplemental cash flow information:      
Cash paid for interest, net of capitalized interest 26,371 24,266 41,603
Cash paid for income taxes 17,195 10,000 20,000
Supplemental non-cash transactions:      
Change in accrued capital expenditures 45,513 (21,668) 8,304
Change in asset retirement obligations 1,238 852 14,724
Non-cash consideration exchanged in Merger 0 2,585,211 0
Investment in unconsolidated affiliate 0 568,312 0
Note receivable from divestiture 0 0 2,900
Contingent consideration from Permian Basin Sale 0 0 32,860
Dividends payable $ 37,553 $ 30,630 $ 4,946